Literature DB >> 17125772

Response to 'Laurberg JM, Olsen AK, Hansen SB, et al. Imaging of vulnerable atherosclerotic plaques with FDG-microPET: no FDG accumulation' [Atherosclerosis 2006].

J H F Rudd, Z A Fayad, J Machac, P L Weissberg, J R Davies, E A Warburton, A A Tawakol, H W Strauss, V Fuster.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17125772     DOI： 10.1016/j.atherosclerosis.2006.10.027

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN： 0021-9150            Impact factor:   5.162


× No keyword cloud information.
  10 in total

Review 1.  Emergence of molecular imaging of aortic aneurysm: implications for risk stratification and management.

Authors:  Reza Golestani; Mehran M Sadeghi
Journal:  J Nucl Cardiol       Date:  2014-01-01       Impact factor: 5.952

Review 2.  FDG PET imaging and cardiovascular inflammation.

Authors:  Nadine Hiari; James H F Rudd
Journal:  Curr Cardiol Rep       Date:  2011-02       Impact factor: 2.931

3.  Molecular Imaging of Inflammation in a Mouse Model of Atherosclerosis Using a Zirconium-89-Labeled Probe.

Authors:  Björn Gustafsson; Kenneth Caidahl; Mona Ahmed; Tetyana Tegnebratt; Thuy A Tran; Li Lu; Peter Damberg; Anton Gisterå; Laura Tarnawski; Dianna Bone; Ulf Hedin; Per Eriksson; Staffan Holmin
Journal:  Int J Nanomedicine       Date:  2020-08-14

Review 4.  Emerging role of FDG-PET/CT in assessing atherosclerosis in large arteries.

Authors:  Wengen Chen; Gonca G Bural; Drew A Torigian; Daniel J Rader; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-11-04       Impact factor: 9.236

Review 5.  Pre-clinical and clinical evaluation of nuclear tracers for the molecular imaging of vulnerable atherosclerosis: an overview.

Authors:  L M Riou; A Broisat; J Dimastromatteo; G Pons; D Fagret; C Ghezzi
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

Review 6.  Positron emission tomography imaging of atherosclerosis.

Authors:  Hakan Orbay; Hao Hong; Yin Zhang; Weibo Cai
Journal:  Theranostics       Date:  2013-11-02       Impact factor: 11.556

7.  Optimizing 18F-FDG PET/CT imaging of vessel wall inflammation: the impact of 18F-FDG circulation time, injected dose, uptake parameters, and fasting blood glucose levels.

Authors:  Jan Bucerius; Venkatesh Mani; Colin Moncrieff; Josef Machac; Valentin Fuster; Michael E Farkouh; Ahmed Tawakol; James H F Rudd; Zahi A Fayad
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-11-23       Impact factor: 9.236

8.  Glucose metabolic trapping in mouse arteries: nonradioactive assay of atherosclerotic plaque inflammation applicable to drug discovery.

Authors:  Richard G Conway; Eyassu Chernet; David C De Rosa; Robert J Benschop; Anne B Need; Emily C Collins; James S Bean; J Michael Kalbfleisch; Mark D Rekhter
Journal:  PLoS One       Date:  2012-11-28       Impact factor: 3.240

9.  Periaortic brown adipose tissue as a major determinant of [¹⁸F]-fluorodeoxyglucose vascular uptake in atherosclerosis-prone, apoE-/- mice.

Authors:  Jakub Toczek; Alexis Broisat; Pascale Perret; Marie-Dominique Desruet; Daniel Fagret; Laurent M Riou; Catherine Ghezzi
Journal:  PLoS One       Date:  2014-07-23       Impact factor: 3.240

10.  Position paper of the Cardiovascular Committee of the European Association of Nuclear Medicine (EANM) on PET imaging of atherosclerosis.

Authors:  Jan Bucerius; Fabien Hyafil; Hein J Verberne; Riemer H J A Slart; Oliver Lindner; Roberto Sciagra; Denis Agostini; Christopher Übleis; Alessia Gimelli; Marcus Hacker
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-12-17       Impact factor: 9.236
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.